Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPM1E | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | DFFB | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | RNF165 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | PCNA | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
mRNA | MAPRE2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
mRNA | ZNF33B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
mRNA | DCAF16 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | ZNF784 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |